Hemodynamic changes in postprandial state

Diabetes and Metabolism

Volumn 32, Issue HS2, 2006, Pages

  Valensi, P ^a,b   Cosson, E ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b HÔPITAL JEAN VERDIER   (France)

Author keywords

Blood pressure; Cardiovascular risk; Endothelial function; Fat load; Oral glucose load; Postprandial blood glucose; Sympathetic activity

Indexed keywords

ACARBOSE; CARBOHYDRATE; FATTY ACID; GLUCOSE;

ARTICLE; BLOOD PRESSURE MEASUREMENT; GLUCOSE INTAKE; HEMODYNAMICS; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; LIPID DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; POSTPRANDIAL STATE; SUGAR INTAKE; ANIMAL; BIOLOGICAL MODEL; BLOOD PRESSURE; CARBOHYDRATE DIET; DRUG EFFECT; FAT INTAKE; PHYSIOLOGY; RAT; REVIEW;

ANIMALS; BLOOD PRESSURE; DIETARY CARBOHYDRATES; DIETARY FATS; GLUCOSE; MODELS, BIOLOGICAL; POSTPRANDIAL PERIOD; RATS;

EID: 34248395576     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1262-3636(06)70484-0     Document Type: Article

References (40)

1. Hanefeld M, Fischer S, Julius U, et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996;39:1577-83.
2. The DECODE Study Group; European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161:397-404.
3. Bonora E, Kiechl S, Oberhollenzer F, et al. Impaired glucose tolerance, type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia 2000;43:156-64.
4. Hanefeld M, Koehler C, Henkel E, Fuecker K, Schaper F, Temelkova-Kurktschiev T. Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk factors in impaired glucose tolerance for atherosclerosis and diabetes. Diabet Med 2000;17:835-40.
5. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension, 1987;10:512-6.
6. Kaufman LN, Peterson MM, Smith SM. Hypertension and sympathetic hyperactivity induced in rats by high-fat or glucose diets. Am J Physiol 1991;260:E95-100.
7. Reaven GM, Ho H. Sugar-induced hypertension in Sprague-Dawley rats. Am J Hypertens 1991;4:610-4
8. Reaven GM, Ho H, Hoffman BB. Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension 1988;12:129-32.
9. Verma S, Bhanot S, McNeill JH. Sympathectomy prevents fructose-induced hyperinsulinemia and hypertension. Eur J Pharmacol 1999;373:R1-4
10. Penicaud L, Berthault MF, Morin J, Dubar M, Ktorza A, Ferre P. Rilmenidine normalizes fructose-induced insulin resistance and hypertension in rats. J Hypertens Suppl 1998;16:S45-9.
11. Claxton CR, Brands MW, Fitzgerald SM, Cameron JA. Inhibition of nitric oxide synthesis potentiates hypertension during chronic glucose infusion in rats. Hypertension 2000;35:451-6.
12. Claxton CR, Brands MW. Nitric oxide opposes glucose-induced hypertension by suppressing sympathetic activity. Hypertension 2003;41:274-8.
13. Tamaya-Mori N, Uemura K, Iguchi A. Gender differences in the dietary lard-induced increase in blood pressure in rats. Hypertension 2002;39:1015-20.
14. Young JB, Daly PA, Uemura K, Chaouloff F. Effects of chronic lard feeding on sympathetic nervous system activity in the rat. Am J Physiol 1994;267:R1320-8.
15. Rousseau D, Helies-Toussaint C, Moreau D, Raederstorff D, Grynberg A. Dietary n-3 PUFAs affect the blood pressure rise and cardiac impairments in a hyperinsulinemia rat model in vivo. Am J Physiol Heart Circ Physiol 2003;285: H1294-302
16. Rousseau D, Moreau D, Raederstorff D, et al. Is a dietary n-3 fatty acid supplement able to influence the cardiac effect of the psychological stress? Mol Cell Biochem 1998;178:353-66.
17. Marfella R, Quagliaro L, Nappo F, Ceriello A, Giugliano D. Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest 2001;108:635-6.
18. Marfella R, Esposito K, Giunta R, et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 2000;101: 2247-51.
19. Berne C, Fagius J, Niklasson F. Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings. J Clin Invest 1989;84:1403-9.
20. Van De Borne P, Hausberg M, Hoffman RP, Mark AL, Anderson EA. Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects. Am J Physiol 1999;276:R178-83.
21. Marfella R, Nappo F, De Angelis L, Siniscalchi M, Rossi F, Giugliano D. The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia 2000;43:571-5.
22. Scott EM, Greenwood JP, Vacca G, Stoker JB, gilbey SG, Mary DA. Carbohydrate ingestion, with transient endogenous insulinaemia, produces both sympathetic activation and vasodilatation in normal humans. Clin Sci (Lond) 2002;102:523-9
23. Valensi P, Dabire H, Belmin J, Brahimi M, Attali JR. Influence de l'activité vago-sympathique sur l'évolution tensionnelle après glucose. Effet du diabète et du vieillissement. Diabetes Metab 2006;32:1S10 [Abstract O10].
24. von Kanel R, Nelesen RA, Le DT, Ziegler MG, Dimsdale JE. Decrease in the plasma von Willebrand factor concentration following glucose ingestion: the role of insulin sensitivity. Metabolism 2001;50:1452-6.
25. Ceriello A, Motz E, Caravape A, et al. Hyperglycemia counterbalances the antihypertensive effect of glutathione in diabetic patients: evidence linking hypertension and glycemia through the oxidative stress in diabetes mellitus. J Diabetes Complications 1997;11:250-5.
26. Valensi P, Doare L, Perret G, Germack R, Paries J, Mesangeau D. Cardiovascular vagosympathetic activity in rats with ventromedial hypothalamic obesity. Obes Res 2003:11:54-64.
27. Dabire H, Brahimi M, Hadj-Brahim F, Le Clesiau H, Attali JR, Valensi P. Role of vagosympathetic balance in obesity-induced hypertension. Arch Mal Coeur Vaiss 2004;97:749-52.
28. Valensi P, Paries J, Attali JR; French Group for Research and Study of Diabetic Neuropathy. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications - the French multicenter study. Metabolism 2003;52:815-20.
29. Valensi P, Thi BN, Lormeau B, Paries J, Attali JR. Cardiac autonomic function in obese patients. Int J Obes Relat Metab Disord 1995;19:113-8.
30. Tentolouris N, Tsigos C, Perea D, et al. Differential effects of high-fat and high-carbohydrate isoenergetic meals on cardiac autonomic nervous system activity in lean and obese women. Metabolism 2003;52:1426-32.
31. Valensi P, Paries J, Lormeau B, Attia S, Attali JR. Influence of nutrients on cardiac autonomic function in nondiabetic overweight subjects. Metabolism, 2005;54:1290-6.
32. Lipsitz LA, Ryan SM, Parker JA, Freeman R, Wei JY, Goldberger AL. Hemodynamic and autonomic nervous system responses to mixed meal ingestion in healthy young and old subjects and dysautonomic patients with postprandial hypotension. Circulation, 1993;87:391-400.
33. Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002;106:1211-8.
34. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003;290:486-94.
35. Wascher TC, Schmoelzer I, Wiegratz A, et al. Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance. Eur J Clin Invest 2005;35:551-7.
36. Hanefeld M, Chiasson JL, Koehler C, Henkel E, Schaper F, Temelkova-Kurktschiev T. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance. Stroke 2004;35:1073-8.
37. Ceriello A, Taboga C, Tonutti L, et al. Post-meal coagulation activation in diabetes mellitus: the effect of acarbose. Diabetologia 1996;39:469-73.
38. Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 2004;25:10-6.
39. Esposito K, Giugliano D, Nappo F, Marfella R; Campanian Postprandial Hyperglycemia Study Group. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 2004;110:214-9.
40. Ceriello A, Assaloni R, Da Ros R, et al. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 2005;11:2518-24.